Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Current Assets (2020 - 2025)

Historic Current Assets for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $103.5 million.

  • SOPHiA GENETICS's Current Assets fell 1170.95% to $103.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.5 million, marking a year-over-year decrease of 1170.95%. This contributed to the annual value of $99.4 million for FY2024, which is 3285.58% down from last year.
  • As of Q3 2025, SOPHiA GENETICS's Current Assets stood at $103.5 million, which was down 1170.95% from $117.0 million recorded in Q2 2025.
  • SOPHiA GENETICS's Current Assets' 5-year high stood at $300.8 million during Q3 2021, with a 5-year trough of $80.2 million in Q2 2021.
  • Its 5-year average for Current Assets is $166.3 million, with a median of $150.6 million in 2023.
  • Per our database at Business Quant, SOPHiA GENETICS's Current Assets soared by 19234.97% in 2022 and then tumbled by 3285.58% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Current Assets stood at $282.9 million in 2021, then crashed by 30.62% to $196.3 million in 2022, then dropped by 24.56% to $148.0 million in 2023, then plummeted by 32.86% to $99.4 million in 2024, then grew by 4.1% to $103.5 million in 2025.
  • Its Current Assets stands at $103.5 million for Q3 2025, versus $117.0 million for Q2 2025 and $90.1 million for Q1 2025.